Arcadia Biosciences Inc (RKDA) — Cash Flow-to-Debt Ratio
Arcadia Biosciences Inc (RKDA) has a Cash Flow-to-Debt Ratio of -0.36x as of December 2025, meaning its operating cash flow of $-861.00K could theoretically repay 0% of its total liabilities ($2.41 Million) in one year. See Arcadia Biosciences Inc (RKDA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Arcadia Biosciences Inc Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Arcadia Biosciences Inc across 14 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Arcadia Biosciences Inc.
Annual Cash Flow-to-Debt Ratio for Arcadia Biosciences Inc (2012–2025)
Year-by-year debt coverage analysis for Arcadia Biosciences Inc. Check Arcadia Biosciences Inc (RKDA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.97x | $-4.74 Million | $2.41 Million | ▼ -49.2% |
| 2024 | -1.32x | $-9.63 Million | $7.29 Million | ▲ +39.6% |
| 2023 | -2.18x | $-15.29 Million | $7.00 Million | ▼ -25.4% |
| 2022 | -1.74x | $-13.98 Million | $8.02 Million | ▲ +14.3% |
| 2021 | -2.03x | $-25.87 Million | $12.72 Million | ▼ -26.5% |
| 2020 | -1.61x | $-30.22 Million | $18.80 Million | ▼ -126.7% |
| 2019 | -0.71x | $-17.20 Million | $24.25 Million | ▲ +41.7% |
| 2018 | -1.22x | $-13.63 Million | $11.21 Million | ▲ +25.4% |
| 2017 | -1.63x | $-13.96 Million | $8.56 Million | ▼ -228.7% |
| 2016 | -0.50x | $-17.05 Million | $34.38 Million | ▼ -11.7% |
| 2015 | -0.44x | $-15.11 Million | $34.02 Million | ▲ +19.6% |
| 2014 | -0.55x | $-14.79 Million | $26.77 Million | ▼ -52.1% |
| 2013 | -0.36x | $-9.74 Million | $26.84 Million | ▲ +27.9% |
| 2012 | -0.50x | $-9.59 Million | $19.04 Million | — |